Learn About Percutaneous Coronary Intervention (PCI)
Cardiology
NewYork-Presbyterian Healthcare System
NewYork-Presbyterian/Columbia University Irving Medical Center
Ajay Kirtane is an Interventional Cardiologist and a Cardiologist in New York, New York. Kirtane has been practicing medicine for over 25 years and is rated as an Elite expert by MediFind in Percutaneous Coronary Intervention (PCI). He is also highly rated in 33 other conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in Massachusetts, California, and New York. Kirtane is currently accepting new patients.
Cardiology
OU Health
Cardiology, Pulmonary & Vascular Medicine Clinic
Usman Baber is an Interventional Cardiologist and a Cardiologist in Oklahoma City, Oklahoma. Baber has been practicing medicine for over 19 years and is rated as an Elite expert by MediFind in Percutaneous Coronary Intervention (PCI). He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in New York and Oklahoma. Baber is currently accepting new patients.
Cardiology
NewYork-Presbyterian Healthcare System
NewYork-Presbyterian/Columbia University Irving Medical Center
Jeffrey Moses is an Interventional Cardiologist and a Cardiologist in New York, New York. Moses has been practicing medicine for over 49 years and is rated as an Elite expert by MediFind in Percutaneous Coronary Intervention (PCI). He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in New York. Moses is currently accepting new patients.
Summary: The purpose of this study is to collect real-world data on the TherOx DownStream System® to assess the effectiveness and cost- effectiveness of SSO2 Therapy, compared with PCI alone for treatment of patients with acute anterior MI.
Summary: The objective of this clinical trial is to confirm the safety, effectiveness and performance of the DESyne BDS Plus Drug Eluting Coronary Stent System (DESyne BDS Plus DECSS) (Test) as compared to the CE Mark approved DESyne X2 Novolimus Eluting Coronary Stent System (DESyne X2 NECSS; DESyne X2) (Control) in the treatment of de novo native coronary artery lesions.